Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Risk scoring tool to predict respiratory syncytial virus hospitalisation in premature infants.
Journal: Pediatric pulmonology
Published: November 07, 2017
CHD and respiratory syncytial virus: global expert exchange recommendations.
Journal: Cardiology in the young
Published: June 17, 2017
Burden of Severe Respiratory Syncytial Virus Disease Among 33-35 Weeks' Gestational Age Infants Born During Multiple Respiratory Syncytial Virus Seasons.
Journal: The Pediatric infectious disease journal
Published: October 19, 2016
Review of the home care programmes for respiratory syncytial virus (RSV) prophylaxis in Ireland and The Netherlands.
Journal: Drugs & therapy perspectives : for rational drug selection and use
Published: March 01, 2016
The Burden of Severe Respiratory Syncytial Virus Disease Among Children Younger than 1 Year in Central and Eastern Europe.
Journal: Infectious diseases and therapy
Published: February 11, 2016
Safety and pharmacokinetics of extended use of palivizumab in Saudi Arabian infants and children.
Journal: Drugs in context
Published: November 26, 2014
The burden of single virus and viral coinfections on severe lower respiratory tract infections among preterm infants: a prospective birth cohort study in Brazil.
Journal: The Pediatric infectious disease journal
Published: November 01, 2014
Safety and Effectiveness of Palivizumab in Children at High Risk of Serious Disease Due to Respiratory Syncytial Virus Infection: A Systematic Review.
Journal: Infectious diseases and therapy
Published: July 31, 2014
Palivizumab use in Japanese infants and children with immunocompromised conditions.
Journal: The Pediatric infectious disease journal
Published: May 17, 2014
Three monthly doses of palivizumab are not adequate for 5-month protection: a population pharmacokinetic analysis.
Journal: Pulmonary pharmacology & therapeutics
Published: July 23, 2012
A prospective, open-label, non-comparative study of palivizumab prophylaxis in children at high risk of serious respiratory syncytial virus disease in the Russian Federation.
Journal: BMC research notes
Published: March 23, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026